BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23226233)

  • 1. Immunological and biochemical characterization of coxsackie virus A16 viral particles.
    Chong P; Guo MS; Lin FH; Hsiao KN; Weng SY; Chou AH; Wang JR; Hsieh SY; Su IJ; Liu CC
    PLoS One; 2012; 7(11):e49973. PubMed ID: 23226233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system.
    Liu CC; Guo MS; Lin FH; Hsiao KN; Chang KH; Chou AH; Wang YC; Chen YC; Yang CS; Chong PC
    PLoS One; 2011; 6(5):e20005. PubMed ID: 21603631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles.
    Liu CC; Guo MS; Wu SR; Lin HY; Yang YT; Liu WC; Chow YH; Shieh DB; Wang JR; Chong P
    Antiviral Res; 2016 May; 129():58-66. PubMed ID: 26899790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological evaluation and comparison of different EV71 vaccine candidates.
    Chou AH; Liu CC; Chang JY; Lien SP; Guo MS; Tasi HP; Hsiao KN; Liu SJ; Sia C; Wu SC; Lee MS; Hsiao CH; Wang JR; Chow YH; Chong P
    Clin Dev Immunol; 2012; 2012():831282. PubMed ID: 23008736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures of Coxsackievirus A16 Capsids with Native Antigenicity: Implications for Particle Expansion, Receptor Binding, and Immunogenicity.
    Ren J; Wang X; Zhu L; Hu Z; Gao Q; Yang P; Li X; Wang J; Shen X; Fry EE; Rao Z; Stuart DI
    J Virol; 2015 Oct; 89(20):10500-11. PubMed ID: 26269176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poorly neutralizing polyclonal antibody in vitro against coxsackievirus A16 circulating strains can prevent a lethal challenge in vivo.
    Yao X; Mao Q; Li Y; Hao C; Bian L; Chen P; Gao F; Wu X; Lu W; Gao Q; Li X; Liang Z
    Hum Vaccin Immunother; 2018 May; 14(5):1275-1282. PubMed ID: 29337652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
    Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
    Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity studies of bivalent inactivated virions of EV71/CVA16 formulated with submicron emulsion systems.
    Lin CW; Liu CC; Lu TC; Liu SJ; Chow YH; Chong P; Huang MH
    Biomed Res Int; 2014; 2014():670506. PubMed ID: 25006583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
    Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
    Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
    Lyu K; He YL; Li HY; Chen R
    J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease.
    Tsou YL; Lin YW; Shao HY; Yu SL; Wu SR; Lin HY; Liu CC; Huang C; Chong P; Chow YH
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003692. PubMed ID: 25855976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing Enterovirus 71 and Coxsackievirus A16 virus-like particles production in insect cells.
    Somasundaram B; Chang C; Fan YY; Lim PY; Cardosa J; Lua L
    Methods; 2016 Feb; 95():38-45. PubMed ID: 26410190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 3.0-Angstrom Resolution Cryo-Electron Microscopy Structure and Antigenic Sites of Coxsackievirus A6-Like Particles.
    Chen J; Zhang C; Zhou Y; Zhang X; Shen C; Ye X; Jiang W; Huang Z; Cong Y
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis and solution of false-positives when testing CVA16 sera using an antibody assay against the EV71 virus.
    Wang C; You A; Tian X; Zhao M; Chen Y; Lin T; Zheng J; Xiao M; Zhang Y; Kuang L; Zhou Z; Zhu B
    Virus Res; 2013 Sep; 176(1-2):33-6. PubMed ID: 23707400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity.
    Zhang W; Dai W; Zhang C; Zhou Y; Xiong P; Wang S; Ye X; Liu Q; Zhou D; Huang Z
    Emerg Microbes Infect; 2018 May; 7(1):94. PubMed ID: 29777102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Antibodies with Non-overlapping Neutralization Sites that Target Coxsackievirus A16.
    He M; Xu L; Zheng Q; Zhu R; Yin Z; Zha Z; Lin Y; Yang L; Huang Y; Ye X; Li S; Hou W; Wu Y; Han J; Liu D; Li Z; Chen Z; Yu H; Que Y; Wang Y; Yan X; Zhang J; Gu Y; Zhou ZH; Cheng T; Li S; Xia N
    Cell Host Microbe; 2020 Feb; 27(2):249-261.e5. PubMed ID: 32027857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates.
    Chou AH; Liu CC; Chang CP; Guo MS; Hsieh SY; Yang WH; Chao HJ; Wu CL; Huang JL; Lee MS; Hu AY; Lin SC; Huang YY; Hu MH; Chow YH; Chiang JR; Chang JY; Chong P
    PLoS One; 2012; 7(4):e34834. PubMed ID: 22529942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycyrrhizic acid as the antiviral component of Glycyrrhiza uralensis Fisch. against coxsackievirus A16 and enterovirus 71 of hand foot and mouth disease.
    Wang J; Chen X; Wang W; Zhang Y; Yang Z; Jin Y; Ge HM; Li E; Yang G
    J Ethnopharmacol; 2013 May; 147(1):114-21. PubMed ID: 23454684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of EV71 vaccine candidates.
    Chong P; Hsieh SY; Liu CC; Chou AH; Chang JY; Wu SC; Liu SJ; Chow YH; Su IJ; Klein M
    Hum Vaccin Immunother; 2012 Dec; 8(12):1775-83. PubMed ID: 22992566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Broadly Cross-protective Vaccine Presenting the Neighboring Epitopes within the VP1 GH Loop and VP2 EF Loop of Enterovirus 71.
    Xu L; He D; Yang L; Li Z; Ye X; Yu H; Zhao H; Li S; Yuan L; Qian H; Que Y; Kuo Shih JW; Zhu H; Li Y; Cheng T; Xia N
    Sci Rep; 2015 Aug; 5():12973. PubMed ID: 26243660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.